Kobo Biotech Ltd-$ logo

Kobo Biotech Ltd-$ share price

BSE: 531541Chemicals & PetrochemicalsSmall Cap

Last close ₹4.10down ₹0.01 (0.24%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹4.11.

52-week range of traded prices to 23 Oct 2026
₹1.99Low, 11 Dec 2025₹9.99High, 20 Jul 2026
Market cap
₹9.77 Cr4,799th largest listed
P/E
No recent results
P/B
No recent results
Dividend yield
Nonein the last 12 months
Volume, BSE
7,436

Share price

Daily closes since Jan 2007, adjusted for splits and bonuses

+38.5%over a year · Nifty 500 −9.8%

20-session average 13,211 shares a day

Results

Standalone; ₹ crore, the charts by years to March, the table by quarter. No standalone results on record for the year to Mar 2016.Quarterly results

Quarter to Jun 2024, against the quarter beforeFiled 21 Aug

Revenue
₹0.00 CrQuarter to Mar 2024: ₹0.00 Cr
Net profit
−₹1.33 CrQuarter to Mar 2024: −₹1.26 Cr

Revenue by year

Peak revenue ₹29 Cr, year to Mar 2015

Net profit by year, a loss in red

  • Net profit
  • Loss
A loss in 9 of the 9 years with results on record
₹ croreSep 2022Filed 25 NovDec 2022Filed 16 FebMar 2023Filed 30 MayJun 2023Filed 11 AugSep 2023Filed 28 NovDec 2023Filed 26 FebMar 2024Filed 2 JulJun 2024Filed 21 Aug
Revenue0.000.000.000.000.000.000.000.00
Net profit−1.10−1.19−1.79−1.23−1.22−1.23−1.26−1.33
Standalone. The last eight quarters. The latest is shaded.

Business segments

In the year to Mar 2024 the company reports one business segment, Manufacturing Active Pharmaceutical Ingredients (API)/ Bulk Drugs, which carries all its revenue.

Where the return came from

Yearly rates to Mar 2024, per-share figures restated for splits and bonuses.

OverReturn a yearEarnings growthChange in P/EDividend yield
1 year+100.0%––0.0%
3 years−19.9%––0.0%
5 years−3.7%––0.0%
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record. Earnings growth over 1, 3 and 5 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.

Who owns it

Per cent of the company's shares, from the filing for Jun 2026.Shareholding pattern

Shareholding by group

  • Promoters44.95%
  • Individuals and others55.05%
Holder
ARCH PHARMALABS LTDPromoter44.95%
SANJAY LUTHRAResident individuals, over ₹2 lakh at face value1.06%
Holders are named in the company's own words: an insurer's holding can carry one of its funds' names.

Peers and competitors

Commodity Chemicals, 74 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Kobo Biotech Ltd-$ in market cap. 1 company in the table last traded before then: its row is priced on its last trade.

Kobo Biotech Ltd-$ is not on the chart: it has no P/E or return on equity today

Return on equity across, P/E up, size is market cap
Company
Vivid Global Industries logoVivid Global IndustriesVIVIDIND1620.61.05.7+52.3%+71.9%4.9%9.1%0.00%
Link Pharma Chem logoLink Pharma ChemLINKPH11–0.813.8+16.3%–−0.1%1.2%0.00%
Emmessar Biotech & Nutrition logoEmmessar Biotech & NutritionEMMESSA1126.51.3–−46.0%−0.6%5.0%−18.8%0.00%
Sree chem Resins logoSree chem ResinsSRECR10–0.735.9−15.5%––−1.1%0.00%
Kuwer Industries logoKuwer IndustriesKUWERIN10–0.5–+34.8%––−6.2%0.00%
Lime Chemicals logoLime ChemicalsLIMECHM8–4.5–+35.5%––−3.0%0.00%
Bhagwati Oxygen logoBhagwati OxygenBHAGWOX82.71.1–−34.4%–53.0%−17.2%0.00%
Omkar Pharmachem logoOmkar PharmachemOMKARPH785.60.261.7−22.2%−52.3%0.4%0.3%0.00%
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.

Dividends

Per share, by the year it was paid for, and the latest payments.Dividend history and dates

Ex-dateTypePer share
21 Sep 2012Final₹1.00
22 Jul 2011Final₹1.00
23 Sep 2010Final₹1.00
Latest payments, as declared, by ex-date.

Latest announcements

Routine notices left out.Share news and announcements

Kobo Biotech Ltd-$ share price by year

Each calendar year to 2025.Kobo Biotech Ltd-$ share price history

YearClose at year endChangeHighest closeLowest close
20252.39−44.9%4.132.09
20244.34+40.0%5.732.74
20233.10−16.7%4.291.90
20223.72−64.0%11.323.48
202110.33+18.3%10.333.51
20208.73+164.5%10.291.90
20193.30−52.8%7.001.25
20186.99−50.9%20.264.60
201714.25+24.7%14.254.45
201611.43−70.4%43.306.61
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before.

Recent sessions

The last 10 trading days to 23 Oct 2026, as traded on BSE.

DateOpenHighLowCloseAverage priceVolume
23 Oct 20264.104.104.104.104.107,436
22 Oct 20264.114.114.114.114.112,563
21 Oct 20264.194.194.194.194.194,111
19 Oct 20264.274.274.274.274.27110
16 Oct 20264.354.364.354.354.359,716
15 Oct 20264.434.474.434.434.436,970
14 Oct 20264.524.704.524.524.566,316
13 Oct 20264.595.044.594.615.0011,399
12 Oct 20264.814.814.594.804.8018,394
9 Oct 20264.594.594.404.594.5881,160
Prices in ₹ per share as traded, not adjusted.

Company details

Legal name
KOBO BIOTECH LIMITED
BSE code
531541
ISIN
INE881A01015
Industry
Chemicals & Petrochemicals
Listed
Mar 2000
Face value
₹10
CIN
L24110TG1993PLC016112
Corporate identity number, the registrar of companies' code for it